Founder & Director of the Integrative Gastroenterology unit at Sheba Medical Center. Co-founder and Head of R&D at Evinature.
After founding the Integrative Gastroenterology unit at Sheba Medical Center, Nir Salomon launched a decade-long research project with Professor Shomron Ben-Horin to advance the full potential of neutraceutical therapies for Inflammatory Bowel Disease.
From 2011 to 2022, Salomon led a series of successful trials on the combined use of gut-directed curcumin and Qing Dai (CurQD®) on patients with UC, earning prestigious awards for “breakthrough innovation” and “clinical merit” in his work. His multi-center, international, investigator-initiated placebo-controlled trial on CurQD® was presented at the Crohn’s and Colitis Foundation of America (CCFA), where it was awarded Poster of Distinction.
In 2021, Salomon and Ben-Horin founded Evinature in partnership with Sheba Medical Center (one of Newsweek’s top 10 hospitals) to provide affordable, accessible, and effective therapies to IBD patients.
Salomon lectures worldwide, advocating integrative, evidence-based therapies at prominent medical conferences. He is currently building a global network of leading IBD doctors to facilitate collaborative research projects in the field of nutraceuticals with an aim to advance medical accessibility for patients worldwide.
Stay informed with the latest trials, treatments & fresh arrivals: